Nutex Health
NUTX
117 hedge funds and large institutions have $432M invested in Nutex Health in 2025 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 35 increasing their positions, 34 reducing their positions, and 9 closing their positions.
244% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 9
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
74% more capital invested
Capital invested by funds: $249M → $432M (+$183M)
23% more funds holding
Funds holding: 95 → 117 (+22)
3% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 34
6.26% less ownership
Funds ownership: 43.39% → 37.13% (-6.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Topline Capital Management
Santa Monica,
California
|
+$15.8M |
| 2 |
PP
Pertento Partners
London,
United Kingdom
|
+$7.16M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.81M |
| 4 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
+$2.79M |
| 5 |
BlackRock
New York
|
+$2.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$8.38M |
| 2 |
Millennium Management
New York
|
-$2.53M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.83M |
| 4 |
Jane Street
New York
|
-$1.36M |
| 5 |
Goldman Sachs
New York
|
-$1.35M |
NUTX Hedge Fund Activity: Q4 2025 in Review
117 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Nutex Health (NUTX) for Q4 2025, worth a combined $432M — up 74% from $249M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new NUTX positions and 9 closed out — a net gain of 22 holders — while 35 added to existing stakes and 34 trimmed.
The largest buyer was Topline Capital Management, adding an estimated $15.8M. The largest seller was Morgan Stanley, cutting an estimated $8.38M.
- 117 institutional investors held Nutex Health (NUTX) as of Q4 2025, up from 95 in Q3 2025.
- Funds reported $432M of Nutex Health stock for Q4 2025, up 74% quarter-over-quarter.
- 31 funds opened new Nutex Health positions in Q4 2025 and 9 closed out, a net change of +22 holders.
- The largest Nutex Health buyer in Q4 2025 was Topline Capital Management, an estimated $15.8M added.
- The largest Nutex Health seller in Q4 2025 was Morgan Stanley, an estimated $8.38M sold.
Based on aggregated 13F filings for Q4 2025.